4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-26-000005
Chief Commercial Officer acquired 26,482 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mottiwala Aziz · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-15 | Exercise or conversion : show line 1 in the form | +26,482 | 74,536 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-15 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −4,790 | 0 | D |
| 2026-03-15 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −8,148 | 8,148 | D |
| 2026-03-15 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −8,020 | 16,040 | D |
| 2026-03-15 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −5,524 | 16,574 | D |
Loading xslF345X05/wk-form4_1773779561.xml…